Augmedix, Inc. (AUGX) Company Webcast

Apr 4, 2022

Augmedix, Inc. (NASDAQ: AUGX) delivers industry-leading, ambient medical documentation and data solutions to healthcare systems, physician practices, hospitals, and telemedicine practitioners.

Augmedix is on a mission to help clinicians and patients form a human connection at the point of care, through technology that works in the background and does not interfere with the clinician-patient encounter. Augmedix’s proprietary Notebuilder Platform extracts relevant data from natural clinician-patient conversations and converts that data into medical notes in real time, which are seamlessly transferred to the EHR. The company’s platform uses automatic speech recognition, natural language processing, including large language models, and medical documentation specialists to generate accurate and timely medical notes.

Leveraging this platform, Augmedix’s products relieve clinicians of administrative burden, in turn, reducing burnout and increasing both clinician and patient satisfaction. Augmedix is also leading the revolution in transforming point-of-care information into valuable structured data that can drive lower revenue cycle management costs, higher reimbursement levels and deliver important clinical feedback to the point of care.

Augmedix is headquartered in San Francisco, CA, with offices around the world.

This Company Webcast was recorded during the Lytham Partners Spring 2022 Investor Conference.

Skip to content